R Liesner Selected Research

R Liesner Research Topics

Disease

13	Hemorrhage 11/2018 - 01/2000
12	Hemophilia A (Haemophilia) 05/2018 - 06/2006
4	Hemophilia B (Haemophilia B) 11/2018 - 05/2010
2	Body Weight (Weight, Body) 11/2018 - 07/2018
2	Factor X Deficiency 11/2018 - 01/2009
2	Hypersensitivity (Allergy) 01/2014 - 08/2000
2	Thrombotic Thrombocytopenic Purpura 09/2012 - 12/2000
2	Protein C Deficiency 04/2005 - 09/2004
2	Infections 09/2004 - 08/2000
2	Ischemic Stroke 01/2004 - 04/2001
2	Stroke (Strokes) 01/2004 - 04/2001
1	Hemarthrosis 06/2015
1	Musculoskeletal Diseases (Musculoskeletal Disease) 06/2015
1	von Willebrand Diseases (von Willebrand's Disease) 01/2015
1	Disease Progression 07/2013
1	Thrombasthenia (Glanzmann Thrombasthenia) 03/2008
1	Dehydration (Water Stress) 07/2006
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 07/2006
1	Fetal Distress 07/2006
1	Activated Protein C Resistance (APC Resistance) 04/2005
1	Protein S Deficiency (Deficiency, Protein S) 04/2005
1	Thromboembolism 01/2004
1	Thrombosis (Thrombus) 01/2004
1	Menorrhagia 04/2002
1	Autosomal Recessive 3 Severe Congenital Neutropenia 11/2001
1	Fever (Fevers) 12/2000
1	Hemolytic Anemia 12/2000
1	Thrombocytopenia (Thrombopenia) 12/2000
1	Hermanski-Pudlak Syndrome (Hermansky-Pudlak Syndrome) 11/2000

Drug/Important Bio-Agent (IBA)

6	Factor VIII (Coagulation Factor VIII)IBA 03/2017 - 06/2006
3	Factor IX (Coagulation Factor IX)FDA LinkGeneric 11/2018 - 05/2010
3	Blood Coagulation Factors (Coagulation Factor)IBA 01/2015 - 07/2014
2	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 03/2017 - 03/2016
2	human F8 protein FDA Link 03/2016 - 03/2015
2	factor VIII-Fc fusion proteinIBA 01/2016 - 06/2015
2	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2015 - 09/2007
2	thiamine triphosphorate (TTP)IBA 09/2012 - 12/2000
2	Prothrombin (Factor II)IBA 01/2009 - 04/2005
2	HomocysteineIBA 04/2005 - 04/2001
2	Protein CIBA 04/2005 - 09/2004
2	Retinaldehyde (Retinal)IBA 04/2002 - 11/2000
1	Factor X (Stuart Factor)IBA 11/2018
1	A-factor (Streptomyces)IBA 05/2018
1	emicizumabIBA 05/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 03/2017
1	BAX 855IBA 03/2017
1	N 30IBA 03/2016
1	B-domain-deleted factor VIIIIBA 03/2015
1	recombinant factor VIII SQIBA 03/2015
1	von Willebrand FactorIBA 01/2015
1	3'-(1-butylphosphoryl)adenosineIBA 11/2014
1	EpitopesIBA 01/2014
1	AntibodiesIBA 03/2011
1	Rituximab (Mabthera)FDA Link 05/2009
1	factor V LeidenIBA 07/2006
1	anti-inhibitor coagulant complexIBA 06/2006
1	AntithrombinsIBA 04/2005
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2004
1	Immunoglobulin G (IgG)IBA 01/2004
1	Immunoglobulins (Immunoglobulin)IBA 01/2004
1	Anticardiolipin AntibodiesIBA 01/2004
1	Leukocyte Elastase (Neutrophil Elastase)IBA 11/2001
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 04/2001
1	ADAMTS13 ProteinIBA 12/2000
1	Factor V (Coagulation Factor V)IBA 01/2000

Therapy/Procedure

5	Therapeutics 07/2018 - 05/2010
2	Operative Surgical Procedures 11/2018 - 07/2018
2	Catheters 07/2006 - 08/2000
1	Erythrocyte Transfusion 07/2018
1	Intravenous Infusions 06/2015
1	Stem Cell Transplantation 03/2008
1	Subcutaneous Infusions 09/2004
1	Central Venous Catheters 09/2004